BP PLC
07 January 2003
January 7, 2003
BP TO SELL SERICOL TO SARATOGA PARTNERS
BP announced today that it has reached agreement to sell Sericol, the speciality
printing chemicals business of Burmah Castrol, to funds managed by Saratoga
Partners, a New York-based investment firm specialising in private equity
investments.
Sericol will be purchased from Burmah Castrol plc and its affiliates for £74.5
million in cash and assumed debt. Subject to regulatory and other approvals, the
companies expect to complete the transaction during the first quarter of 2003.
Sericol is a world leader in the supply of printing solutions to the global
screen printing industry, with products including premium inks and other
consumables together with strong technical and advisory services.
Its main manufacturing facilities are at Broadstairs, UK, and Kansas City,
Missouri, USA and it has other manufacturing operations in Australia, India,
China and Brazil. Sericol employs around 1,200 staff worldwide. In 2002, Sericol
had a turnover of some £130 million.
Saratoga Partners specialises in making private equity investments in
partnership with management in the manufacturing, business services, and media
and telecommunications, industries. Following the completion of the purchase,
Sericol will continue to be led by the existing management team, headed by chief
executive Ed Carhart.
Gordon Souter, BP business unit leader Castrol Chemicals, said: 'When we bought
Burmah Castrol in 2000 we knew that, although it was a good business, Sericol
did not fit with the rest of our portfolio and that we would look to dispose of
it. We believe this deal reflects the true value of the business and will
provide a good future for Sericol and its staff.'
BP was advised in this sale by Credit Suisse First Boston.
Further enquiries:
David Nicholas, BP press office, tel: +44 (0)20 7496 4708
- ENDS -
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.